Market Review: Indevus Pharmaceuticals, Inc. Under Current ... - Trading Markets (press release)
... for overactive bladder, VANTAS for advanced prostate cancer, SUPPRELIN LA for central precocious puberty, and DELATESTRYL to treat male hypogonadism. ...